Compugen Ltd. (NASDAQ:
CGEN) today announced that the Company will host a conference call
at 10:00 AM EDT on Tuesday, August 5, 2014 to review the second quarter
2014 results. The quarterly results will be released on the Company's
prior to the conference call.
To access the conference call, please dial 1-888-407-2553 from the US,
or + 972-3-9180610 internationally. The call will also be available via
live webcast through Compugen's website, located at the followig link.
A replay of the conference call will be available approximately two
hours after the completion of the live conference call. To access the
replay, please dial 1-877-456-0009 from the US or +972-3-925-5925
internationally. The replay will be available through August 7, 2014.
About CompugenCompugen is a leading drug discovery company
focused on therapeutic proteins and monoclonal antibodies to address
important unmet needs in the fields of immunology and oncology. The
Company utilizes a broad and continuously growing integrated
infrastructure of proprietary scientific understandings and predictive
platforms, algorithms, machine learning systems and other computational
biology capabilities for the in silico (by computer)
prediction and selection of product candidates, which are then advanced
in its Pipeline Program. The Company's business model includes
collaborations covering the further development and commercialization of
product candidates at various stages from its Pipeline Program and
various forms of research and discovery agreements, in both cases
providing Compugen with potential milestone payments and royalties on
product sales or other forms of revenue sharing. Compugen's wholly-owned
U.S. subsidiary located in South San Francisco is developing oncology
and immunology monoclonal antibody therapeutic candidates against its
drug targets. For additional information, please visit Compugen's
corporate website at www.cgen.com.
[ Back To NFVZone's Homepage ]